These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 28570392

  • 1. Primary Cutaneous Small Cell Variant of Anaplastic Large Cell Lymphoma: A Case Series and Review of the Literature.
    Magro CM, Momtahen S, Kiuru M.
    Am J Dermatopathol; 2017 Dec; 39(12):877-889. PubMed ID: 28570392
    [Abstract] [Full Text] [Related]

  • 2. Primary cutaneous Ki-1(CD30) positive anaplastic large cell lymphoma in childhood.
    Tomaszewski MM, Moad JC, Lupton GP.
    J Am Acad Dermatol; 1999 May; 40(5 Pt 2):857-61. PubMed ID: 10321635
    [Abstract] [Full Text] [Related]

  • 3. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
    Querfeld C, Khan I, Mahon B, Nelson BP, Rosen ST, Evens AM.
    Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cutaneous anaplastic large cell lymphomas: a report of 9 cases from Thailand.
    Eimpunth S, Sittinamsuwan P, Pattanaprichakul P, Silpa-archa N, Sethabutra P, Chularojanamontri L, Hanamornroongruang S, Mahaisavariya P.
    J Med Assoc Thai; 2012 Mar; 95(3):437-43. PubMed ID: 22550845
    [Abstract] [Full Text] [Related]

  • 7. Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative.
    Kadin ME, Pinkus JL, Pinkus GS, Duran IH, Fuller CE, Onciu M, Kawaguchi H, Morris SW.
    Am J Surg Pathol; 2008 Sep; 32(9):1421-6. PubMed ID: 18670345
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cutaneous CD30-positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases.
    Plaza JA, Feldman AL, Magro C.
    J Cutan Pathol; 2013 Feb; 40(2):236-47. PubMed ID: 23189966
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
    Kempf W, Kutzner H, Cozzio A, Sander CA, Pfaltz MC, Müller B, Pfaltz M.
    Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus in CD30 anaplastic large cell lymphoma involving the skin and lymphomatoid papulosis in South Korea.
    Kim YC, Yang WI, Lee MG, Kim SN, Cho KH, Lee SJ, Lee MW, Koh JK.
    Int J Dermatol; 2006 Nov; 45(11):1312-6. PubMed ID: 17076712
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cutaneous anaplastic large-cell lymphoma (ALCL): A comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site.
    Lee WJ, Moon IJ, Lee SH, Won CH, Chang SE, Choi JH, Moon KC, Park CS, Huh J, Lee MW.
    J Am Acad Dermatol; 2016 Jun; 74(6):1135-43. PubMed ID: 26897385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.